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The ability to sequence genomes has far outstripped
approaches for deciphering the information they
encode. Here we present a suite of techniques,
based on ribosome profiling (the deep sequencing
of ribosome-protected mRNA fragments), to provide
genome-wide maps of protein synthesis as well
as a pulse-chase strategy for determining rates of
translation elongation. We exploit the propensity of
harringtonine to cause ribosomes to accumulate
at sites of translation initiation together with a
machine learning algorithm to define protein prod-
ucts systematically. Analysis of translation in mouse
embryonic stem cells reveals thousands of strong
pause sites and unannotated translation products.
These include amino-terminal extensions and trun-
cations and upstream open reading frames with
regulatory potential, initiated at both AUG and
non-AUG codons, whose translation changes after
differentiation. We also define a class of short,
polycistronic ribosome-associated coding RNAs
(sprcRNAs) that encode small proteins. Our studies
reveal an unanticipated complexity to mammalian
proteomes.INTRODUCTION
In the 10 years since the publication of draft human genomes
(Lander et al., 2001; Venter et al., 2001), extraordinary advances
in DNA sequencing technology (Bentley et al., 2008) havemade it
possible to obtain comprehensive genomic information rapidly
and at low cost. Decoding the information contained in these
genomes represents a central challenge for the biological
community. Protein-coding regions have been defined accord-
ing to simple rules about the nature of translation—for example,
that open reading frames (ORFs) have a minimum length, have
biased codon usage, and start at the first AUG in a transcript(Brent, 2005). Yet there are many exceptions to these rules,
including internal ribosome entry sites, initiation at non-AUG
codons, leaky scanning, translational reinitiation, and transla-
tional frameshifts (Atkins and Gesteland, 2010). Additionally, an
abundant class of large intergenic noncoding RNAs (lincRNAs)
that do not contain canonical ORFs has been recently been
described (Guttman et al., 2009, 2010). Many of these lincRNA
transcripts are likely to be functional RNAs, but there are well-
documented cases of biologically important short coding
regions. For example, the Drosophila tarsal-less/polished rice
gene was originally thought to be a lincRNA (Tupy et al., 2005)
but actually encodes a series of short peptides that modulate
the activity of the shavenbaby transcription factor (Kondo
et al., 2010). The question of which of the potential lincRNAs
are actually translated remains largely unaddressed.
We also know that the rate of translation is not constant across
a message, and translation pauses can regulate synthesis (Dar-
nell et al., 2011; Morris and Geballe, 2000), folding (Kimchi-Sar-
faty et al., 2007; Zhang et al., 2009), and localization of a protein
(Mariappan et al., 2010) or mRNA (Yanagitani et al., 2011). These
pauses can results from codon usage (Irwin et al., 1995), mRNA
structure (Namy et al., 2006), or peptide sequence (Nakatogawa
and Ito, 2002; Tenson and Ehrenberg, 2002), but little information
exists on how generally they occur, let alone their functional
impact.
Recently, we described a strategy, termed ribosome profiling,
based on deep sequencing of ribosome-protected mRNA frag-
ments, that makes it possible to monitor translation with a depth,
speed, and accuracy that rival existing approaches for following
mRNA levels (Guo et al., 2010; Ingolia et al., 2009). By revealing
the precise locations of ribosomes on each mRNA, ribosome
profiling also has the potential to identify protein-coding regions.
However, initiation from multiple sites within a single transcript
makes it challenging to define all ORFs, especially in complex
transcriptomes. Additionally, ribosome profiling provides a
snapshot of ribosome positions but does not report directly on
the kinetics of translational elongation or distinguish stalled
ribosomes from those engaged in active elongation.
Here we describe a simplified, robust protocol for ribosome
profiling in mammalian systems. We have used this technique
to determine the kinetics of translation by following run-offCell 147, 789–802, November 11, 2011 ª2011 Elsevier Inc. 789
elongation after stalling new initiation using the drug harringto-
nine (Fresno et al., 1977; Huang, 1975; Robert et al., 2009;
Tscherne and Pestka, 1975). We further employ harringtonine,
which causes ribosomes to accumulate precisely at initiation
codons, together with a machine learning algorithm, to define
the sites of translation initiation genome-wide. Application of
our approach to mouse embryonic stem cells (mESCs) reveals
a wide range of unannotated or modified ORFs, including highly
translated short ORFs in the majority of annotated lincRNAs. We
now classify these atypical protein-coding transcripts as short,
polycistronic ribosome-associated RNAs (sprcRNAs). Addition-
ally, we identify over a thousand strong translational pauses
that could act as key regulatory sites. Our approach is readily
applicable to other cells and organisms and as such provides
a general scheme for decoding complex genomes, monitoring
rates of protein production, and exploring the molecular mecha-
nisms used to regulate translation.
RESULTS
A Simplified Mammalian Ribosome-Profiling Assay
We first describe a simplified ribosome-profiling strategy
suitable for the analysis of mammalian cells. In general terms,
the assay involves three distinct steps, each of which has been
refined: (1) generation of cell extracts in which ribosomes have
been faithfully halted along themRNA they are translating in vivo;
(2) nuclease digestion of RNAs that are not protected by the
ribosome followed by recovery of the ribosome-protected
mRNA fragments; (3) quantitative conversion of the protected
RNA fragments into a DNA library that can be analyzed by
deep sequencing (Ingolia, 2010; Ingolia et al., 2009; Lau et al.,
2001; Pfeffer et al., 2005). After nuclease treatment, we purified
ribosomes and the associated mRNA footprints by ultracen-
trifugation through a sucrose cushion rather than by sucrose
density gradient fractionation, which is a more specialized tech-
nique. Protected mRNA fragments from single ribosomes were
purified by PAGE, as fragments that derive from other ribosomal
complexes are longer—tightly packed ribosome pairs protect
58–62 nt of mRNA (Wolin andWalter, 1988), and 48S preinitiation
complexes are reported to protect 50 nt or 70 nt under different
conditions (Lazarowitz andRobertson, 1977; Pisarev et al., 2008;
Ule et al., 2003; Chi et al., 2009; Lunde et al., 2007). We gener-
ated libraries from these purified fragments using our previous
published protocol (Ingolia, 2010; Ingolia et al., 2009), modified
to use RNA ligation to attach a linker to the 30 end of the pro-
tected RNA fragment (Lau et al., 2001; Pfeffer et al., 2005). Addi-
tionally, we used subtractive hybridization to substantially
deplete the majority of contaminating ribosomal RNA fragments.
We explored the effects of stabilizing ribosome-mRNA inter-
actions with elongation inhibitors before cell lysis. We compared
cycloheximide (Schneider-Poetsch et al., 2010) and emetine
pretreatment to a ‘‘no drug’’ approach in which unperturbed
cells were lysed in a buffer that should not support continued
elongation. The density of ribosome footprints on each coding
sequence (CDS), which measures the translation of the gene,
agreed well across the three approaches (cycloheximide versus
no drug, standard deviation (SD) of log2 ratio 0.20, correspond-
ing to a typical 15% inter-replicate difference; cycloheximide790 Cell 147, 789–802, November 11, 2011 ª2011 Elsevier Inc.versus emetine, SD log2 ratio 0.40; emetine versus no drug, SD
log2 ratio 0.41) (Figure 1A). We concluded that brief treatment
of cells with elongation inhibitors did not significantly change
which transcripts were associated with ribosomes and did not
distort translation measurements made by ribosome profiling.
Thus, pretreatment can be chosen based on experimental con-
straints. For example, elongation inhibitors would preserve
the cellular state of translation during manipulations such as
fluorescence-activated cell sorting (FACS), whereas flash-
freezing and cryogenic lysis would enable the analysis of tissues
where infusion of translation inhibitors is challenging.
Nonetheless, elongation inhibitors do alter the pattern of
ribosome footprints along transcripts. Footprints derived from
emetine-treated cells are slightly longer than those from un-
treated or cycloheximide-treated cells (Figure 1B and Figures
S1A and S1B available online), suggesting that emetine stabi-
lizes a different ribosome conformation that protects more
mRNA. Furthermore, a metagene analysis, in which many gene
profiles are aligned and then averaged, revealed global differ-
ences in ribosome density at the beginning and ends of ORFs.
The excess of ribosomes at the initiation site and extending
over the first 5 to 10 codons is essentially absent from untreated
cells (Figure 1C). Such an excess would result from the inhibition
of translation elongation in the presence of continuing initiation.
Beyond the initial 5 to 10 codon window, we saw no global
variation in ribosome density along CDSes in any sample. An
earlier analysis had suggested that the excess ribosomes ex-
tending over 100 codons at the beginning of Saccharomyces
cerevisiae ORFs reflected a broadly conserved ‘‘ramping’’
strategy that minimized ribosome stacking and collisions later
in the messages (Tuller et al., 2010). Although it is possible that
such a ramping effect occurs in S. cerevisiae, it does not appear
to occur mammalian cells.
Drug pretreatment also eliminates the excess of ribosomes
seen at the stop codon in untreated cells (Figure 1D). The accu-
mulation is still seen when cells are lysed in the presence of
a nonhydrolyzable GTP analog, suggesting that it does not result
from continued elongation in the lysate (N. Stern-Ginossar and
J.S.W., unpublished data). Interestingly, we saw longer foot-
prints at stop codons (Figures 1B and S1B), suggesting that
the accumulating ribosomes are in a different conformation,
as has been seen during termination in vitro (Alkalaeva et al.,
2006). In summary, although drug pretreatment does not distort
measurements of the overall level of translation of a given
message (Figure 1A), caution should be used in interpreting
position-specific information.
We characterized translation in an mESC line (E14 mESCs),
with matched ribosome-profiling and mRNA-seq data. We
used ribosome footprint density within a CDS as a measure of
protein synthesis and determined levels of gene expression
genome-wide (Figure S1C and Tables S1A and S1B). We also
compared protein synthesis with mRNA abundance and
showed that there was a broad distribution encompassing
over a 10-fold range in the amount of protein produced per
transcript (Figure S1D and Tables S1C and S1D). This distribu-
tion is asymmetric, suggesting a maximal rate of protein
production from an mRNA and substantial dynamic range for
decreased translational efficiency. Our data are consistent
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Figure 1. Ribosome Profiling in mESCs
(A) Effect of elongation inhibitors on ribosome density. The number of ribosome footprint reads that align to the body of each CDS (Experimental Procedures) is
plotted for cells that were either untreated or pretreated with cycloheximide (Spearman r = 0.99). The inset shows a histogram of log2 ratios for genes with at least
200 total reads (the threshold shown by the light blue line) normalized by the median ratio (N = 10045, SD = 0.20, corresponding to 15% difference in
measurements).
(B) Ribosome-protected fragment lengths. Plotted is the length distribution of ribosome footprints over the body of messages prepared from cells treated as
indicated, as well as for footprints centered on the stop codon for the untreated cells.
(C)Metagene analysis of translation initiation. Average ribosome read density profiles over 4,994well-expressed genes (Table S1), aligned at their start codon, are
shown for untreated and drug-treated samples.
(D) Metagene analysis of translation termination. As in (C), but alignment was from stop codons.
See also Figure S1 and Table S1.with recent work that indirectly infers translation levels from ab-
solute mRNA and protein abundance measurements (Schwan-
ha¨usser et al., 2011). Notably, they found that translation was
the single largest contributor to protein abundance, highlighting
the value of direct measurements of protein synthesis.
Widespread Presence of Strong Ribosomal Pauses
The density of ribosome footprint reads varies substantially at
different codons within an individual message (Figure 2A). The
footprint count on a codon should be proportional to the average
ribosome dwell time there, so this density variation represents
differences in the speed of the ribosome. Position-specific vari-
ability is pervasive in both yeast and mESC ribosome-profiling
data (Ingolia et al., 2009), but in mammalian translation, we find
more pronounced pauses where ribosome density is 25-fold
or greater than the median density observed across the body
of the gene. Based on a typical elongation rate of 6 codons
per second (see below), the pauses we see last for severalseconds (Figure 2A), which is enough time for the paused ribo-
some-nascent chain (RNC) complex to bind cotranslational
chaperones.
We find thousands of pauses in the body of genes (1500
pauses in 1100 genes found in a set of 4994 well-expressed
genes; Tables S2A and S2B) and at termination codons (420
pauses; Table S2C). Interestingly, we see no evidence that
pausing causes secondary ribosome accumulation 10 codons
upstream, where a following ribosome would collide with the
stalled one (Wolin and Walter, 1988), nor a depletion of ribo-
somes within the 10 codon ‘‘shadow’’ resulting from paused
ribosomes (Figure 2B). The lack of packed ribosomes at
pause sites suggests that ribosome density is typically too low
to cause frequent encounters between upstream elongating
ribosomes and a transiently stalled downstream ribosome
(Arava et al., 2003). Alternately, such a collision might relieve
ribosomal stalling, allowing for the continual presence of a ribo-
some at a pause site while minimizing ribosome sequestration.Cell 147, 789–802, November 11, 2011 ª2011 Elsevier Inc. 791
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Figure 2. Analysis of Translational Stall
Sites
(A) Distribution of per-codon ribosome footprint
counts. The cumulative distribution of footprint
counts at each codon, relative to the median
density across the gene, is plotted, and the 25 3
median threshold used to identify ribosomal stall
sites is indicated. The distribution of density at
stop codons, which are excluded from the overall
distribution, is shown as well, along with the read
densities in randomly fragmented mRNA, which
controls for library generation.
(B) Metagene analysis of translational stalling.
Ribosome footprint densities were averaged after
aligning gene density profiles at internal trans-
lational stall positions (Table S2B).
(C) Peptide motif associated with internal trans-
lational stalling.
(D) Ribosome footprints over peptide motif en-
riched in stall sites. The cumulative distribution of
relative ribosome footprint counts for the all Pro-
Pro-Glu sites and for those encoded by CC(A/T)-
CC(A/T)-GAA are shown along with the more
lenient Pro-(Pro/Gly)-(Asp/Glu) sites and the
overall data from (A).
(E) Ribosome footprint profile on the Sec61b
transcript (median 22.5 footprints per codon).
(F) Ribosome footprint profile on the Xbp1 tran-
script (median 1.0 footprint per codon). Xbp1
undergoes a nonconventional splicing event (Cal-
fon et al., 2002). The unspliced (Xbp1u) CDS is
indicated, along with the site of translational
stalling at Asn256 and the extended CDS in the
spliced (Xbp1s) message.
See also Table S2.The absence of downstream depletion also argues that the
majority of ribosomes continue elongation following these pause
sites.
Analysis of the sequence around the pause sites reveals
a consensus peptide motif (Figure 2C). There is strong enrich-
ment of glutamate or asparate in the A site at strong pauses,
preceded by a proline or glycine and then another proline, with
an additional bias toward the GAA glutamate codon and CC(A/T)
proline codons. Importantly, we see no enrichment for residues
or codons downstream of the A site, which are not yet being de-
coded. We also see no evidence that the pause sites are en-
riched for rare codons. Sites that match the full three-residue
consensus have dramatically reduced elongation rates overall
(Figure 2D). Translation in E. coli is stalled by similar peptide
motifs with a terminal Pro-Pro peptide, in some cases with an
Asp codon in the A site (Tanner et al., 2009). Our findings suggest
that transfer RNA (tRNA) identity and nascent peptide sequence
can influence the kinetics of elongation, whereas even for rare
codons, tRNA recruitment is not rate limiting.
Our analysis also provides insights into the limited number of
previously documented translational pauses. A recent study
observed slow termination of two tail-anchored (TA) proteins
(Sec61b and Vamp) during in vitro translation (Mariappan et al.,
2010). Pausing at the termination codon of TA proteins has792 Cell 147, 789–802, November 11, 2011 ª2011 Elsevier Inc.been proposed to provide time for the recruitment of the inser-
tion machinery before the release of the C-terminal trans-
membrane domain from the ribosome exit channel. Our data
confirmed termination pausing during the Sec61b and Vamp
translation in vivo (Figure 2E), but we found no evidence for
this phenomenon in the majority of other TA proteins (3/32
have pauses), nor was it restricted to TA proteins (stop codon
ribosome density does not differ significantly, Kruskal-Wallis
p 0.25). Instead, pausing at termination codons is a common
feature of translation.
A second prominent example of a translation pause follows
a hydrophobic sequence in the Xbp1 transcription factor (Yana-
gitani et al., 2011). This hydrophobic domain interacts with the
endoplasmic reticulum (ER) membrane and recruits the Xbp1
message RNC complex (Yanagitani et al., 2009). Ribosome
pausing facilitates this cotranslational localization by delaying
the dissociation of the RNC. We confirmed the presence of this
pause and identified its precise position as residue Asn256,
which is the last codon required for translational arrest (Yanagi-
tani et al., 2011) (Figure 2F). The biological roles of the pauses we
identify remain to be established, but many mRNAs are localized
to specific subcellular regions (Martin and Ephrussi, 2009),
including a number of mRNAs found on the ER surface that,
like Xbp1, do not enter the secretory pathway (Kraut-Cohen
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Figure 3. A Pulse-Chase Strategy for
Measuring Translation Elongation Rates
(A) Schematic of the in vivo run-off elongation
experiment.
(B) Metagene analysis of run-off elongation.
Ribosome read density was averaged across 5
codon windows for samples prepared with the
indicated drug treatments.
(C) Rate of ribosome depletion. The codon
position of 50% ribosome depletion is plotted
as a function of harringtonine treatment time.
Linear fit is x(t) = ax + b, a = 5.6 ± 0.5 codons/s,
b = 347 ± 65 codons, root-mean-square devia-
tion (rmsd) 22.5.
(D) Ribosome depletion on subsets of genes.
Data from (C) are plotted, along with comparable
measurements made from the indicated gene
subsets.
(E) Elongation rates on subsets of genes. Elonga-
tion rates, inferred from linear fit as described
in (C), are plotted along with the standard error of
the regressed coefficient.and Gerst, 2010), and so the mechanism described for Xbp1
localization may be more general.
Monitoring Kinetics of Translation
Our knowledge of the kinetics of protein synthesis in vivo has
been based on a limited number of specific messages (Bostro¨m
et al., 1986). We reasoned that we could monitor the kinetics of
in vivo translation directly by tracing run-off elongation using
ribosome profiling. We first stopped new translation using
harringtonine, which effectively blocks initiation by inhibiting
elongation during the first rounds of peptide bond formation
following subunit joining (Fresno et al., 1977; Robert et al.,
2009). We then allowed a short time for run-off elongation before
adding cycloheximide to halt translation by all active ribo-
somes. We varied the time allowed for run-off elongation to
generate a series of snapshots that could be assembled into
a moving picture of translation in vivo (Figure 3A). Metagene
analyses revealed a progressive depletion of ribosomes from
the 50 to the 30 ends of the messages after harringtonine treat-
ment. Following a delay of 60 s, which presumably reflects
the time required for engagement of harringtonine, ribosomes
progress from the 50 ends of transcripts at a rate of 5.6 amino
acids per second (Figures 3B and 3C), which is consistent
with values from previous single-gene measurements (Bostro¨m
et al., 1986).Cell 147, 789–802, NThe rate of translation is remarkably
consistent between different classes of
messages (Figures 3D and 3E). The
kinetics of elongation are independent of
length and protein abundance and are
the same in secreted proteins, whose
translation occurs on the ER surface.
Translation speed is also independent of
codon usage, which is consistent with
the absence of pauses at rare codons.
This is surprising as it is often assumedthat codons corresponding to low-abundance tRNAs are de-
coded more slowly than those read by abundant tRNAs.
Although this may be the case for specific examples, we find
no evidence for a large effect on the overall rate of elongation.
An important practical implication for the universality of the
average rate of elongation is that ribosome footprint density
provides a reliable measure of protein synthesis independent
of the particular gene being translated.
Defining Translation Start Sites
We found that harringtonine treatment also leads to a profound
accumulation of ribosomes at the sites of translation initiation
(Figures 4A and 4B). This effect likely occurs because harringto-
nine binds to free 60S subunits but not those that are joined
into an 80S ribosome. Thus, elongating ribosomes are immune
to harringtonine, whereas a 60S subunit bound by harringtonine
will form an 80S at a start site that does not move forward
(Fresno et al., 1977; Robert et al., 2009). We reasoned that
this accumulation of ribosomes could serve as a basis for
objectively detecting translation initiation. Accordingly, we
used a support vector machine (SVM)-based machine learning
strategy (Joachims, 1999; Noble, 2006) to comprehensively
identify initiation sites from harringtonine-treated ribosome
footprint profiles, using a ‘‘vector’’ of footprint counts around
a candidate translation start site. The SVM model was trainedovember 11, 2011 ª2011 Elsevier Inc. 793
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Figure 4. Harringtonine Enables Automated Identification of Translation Initiation Sites
(A) Effect of harringtonine on ribosome density for a typical gene. Ribosome footprint read count is shown prior to and following harringtonine treatment (150 s)
along the 50 UTR and the beginning of the CDS of Actr2.
(B) Metagene analysis of ribosome footprints surrounding start codons after harringtonine treatment. As in Figure 3B, focusing specifically on the site
of translation initiation and the surrounding codons.
(C) Evaluation of start site prediction analysis. Plotted is the fraction of positive and negative initiation site predictions for start and selected nonstart codons
that were excluded from the training set.
(D) Histogram of initiation sites predicted per transcript.
(E) Distribution of AUG codons and near-AUG codons at predicted sites of translation initiation (left), compared with the overall codon distribution (right).
(F) Classification of reading frames at predicted initiation sites relative to the annotated CDS.
(G) Pattern of initiation and translation on theSwi5 transcript. As in Figure 4A, with the two detected initiation sites shown alongwith the respective reading frames,
one of which produces a conserved amino-terminal extension on the Swi5 protein.
(H) Pattern of initiation and translation on the Ecsit transcript. Four AUG initiation sites are present, two associated with uORFs and two with alternate protein
isoforms of Ecsit.
See also Figure S2 and Table S3.
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on a set of annotated genes to identify features of footprint
profiles that distinguish the start codon from other positions.
These profiles capture not just the accumulation of ribosomes
at the start codon but also the distinctive asymmetric pattern
of reads across flanking codons. Analysis of a distinct testing
set of transcripts not used for training established that this
model recognized 86% of annotated start codons as sites of
translation initiation in comparison to only 1% of other posi-
tions (Figures 4C and S2A). Actual false-negative and false-
positive rates may be considerably lower, as not all annotated
start sites are correct and there is a substantial rate of translation
initiation from noncanonical start sites.
We applied the SVM approach to identify 13,454 candidate
translation start sites within 5000 transcripts that were well-
expressed in our mESCs (Table S2A). The majority (65%) of
these transcripts contain more than one detectable site of
translation initiation, with 16% containing four or more sites
(Figure 4D and Table S3). Although the analysis examined all
potential translation start sites, we observed a dramatic enrich-
ment for AUG (23-fold; Figure 4E), which provides an indepen-
dent line of evidence for the accuracy of the SVM approach.
We also found a strong enrichment for a specific subset of
the near-cognate codons (i.e., codons that differ from AUG by
a single nucleotide) at initiation sites (Figure 4E). Initiation at
near-cognate sites is sometimes resistant to harringtonine
(Starck et al., 2008; N. Stern-Ginossar and J.S.W., unpublished
data), so our analysis may underestimate the true prevalence
of near-cognate initiation.
Characterization of Alternate Open Reading Frames
We classified the reading frames downstream of the initiation
sites we identified based on their relationship to the annotated
ORF (Figure 4F). Nearly half (44%) of the AUG initiation sites
that we found are unannotated, and the majority of these were
downstream of the annotated start and were predicted to
produce N-terminally truncated proteins or ORFs encoded in
alternate reading frames (Figure S2B). In many cases, the
annotated AUG was also used, and the alternate protein may
not be the primary translation product. However, 280 of the
genes with N-terminal truncations lacked detectable initiation
on the annotated AUG, either because the annotated start
codon is skipped in favor of the internal start site that we identi-
fied, or because the transcript is truncated and the annotated
start codon is absent.
A substantial fraction (14%) of the initiation sites we observed
are predicted to produce alternate protein isoforms of known
genes (Figure 4F). We identified 570 genes with potential
N-terminal extensions and 870 with N-terminal truncations in
the 4,994 genes we analyzed. Extensions most often resulted
from near-cognate initiation (Figure S2B), probably because
computational gene annotation selects the first in-frame AUG,
though conservation has been used to identify N-terminal exten-
sions from near-cognate initiation (Ivanov et al., 2011). We found
an N-terminal extension on the DNA repair protein Swi5 (Fig-
ure 4G); its protein sequence is conserved, and there is experi-
mental evidence that endogenous mouse Swi5 is larger than
the annotated 89 amino acid protein (Akamatsu and Jasin,
2010). Our data also revealed information about the proteinproducts resulting from alternative splicing, which are often
difficult to annotate. For instance, the growth factor Igf2 has
two 50 untranslated region (UTR) variants with the same reading
frame annotated in both transcripts, but we observed an iso-
form-specific N-terminal extension (Figure S2C).
The N-terminal truncations are of particular note as they can
produce functionally distinct protein isoforms that lack an entire
amino-terminal domain. For example, alternate start codons in
the Cebpa gene can result in either a full-length transcription
factor or a truncated dominant-negative isoform that contains
the DNA-binding domain but not the full transactivation domain
(Lin et al., 1993). We observe clear evidence of additional
N-terminal truncations that could produce similar antagonistic
products. Internal initiation in the Ets family transcription factor
Etv5 produces a product that lacks the predicted activation
domain (Monte´ et al., 1996) but contains the domain that medi-
ates DNA binding (Monte´ et al., 1994) (Figure S2D). This mecha-
nism is not limited to transcription factors—internal initiation in
the signaling scaffold Ecsit produces a protein nearly identical
to a dominant-negative form created by designed N-terminal
deletion (Figure 4H) (Kopp et al., 1999).
Exploring Translation of sprcRNAs
The above analysis focuses on known coding transcripts, but
recently an abundant class of RNAs, referred to as lincRNAs,
have been identified that lack the characteristics of conventional
protein-coding genes. A limited number of lincRNAs such as
Xist and HotAir have been shown to act at the RNA level in
the nucleus (Brockdorff et al., 1992; Khalil et al., 2009), but the
extent to which putative lincRNAs are translated is not known.
Accordingly, we searched for translated regions within candi-
date lincRNAs (Guttman et al., 2009, 2010) by finding the most
highly ribosome-occupied 90 nt window within the lincRNA
and determining its translational efficiency as the ratio of ribo-
some footprint and mRNA-seq reads (Guttman et al., 2010,
2009). This analysis was very effective at distinguishing between
traditional translated CDSes and their 30 UTRs, which are poorly
translated (Figure 5A).
Remarkably, the majority of putative lincRNAs contain regions
of high translation comparable to protein-coding genes (Fig-
ure 5A and Table S4). We saw specific start sites marked by
harringtonine followed by ribosome footprints extending to the
first in-frame stop codon (Figures 5B–5D) (Clemson et al.,
2009). These data establish that the majority of lincRNAs are
exported to the cytoplasm and effectively engaged by the
protein translation machinery. These included roughly half of
the lincRNA candidates that were recently shown to be required
for maintenance of pluripotency (Guttman et al., 2011). We
classify these RNAs as sprcRNAs based on our observation
that they contain small CDSes that are bound by elongating
ribosomes and frequently contain multiple ORFs. We also iden-
tify a significant subset of true lincRNAs that are not translated,
including the well-documented RNA element NEAT1, which
regulates mRNA export (Clemson et al., 2009). The extent to
which various RNAs act through their translation products
and/or directly through their transcript remains a central open
question that our dataset should provide a critical resource for
addressing.Cell 147, 789–802, November 11, 2011 ª2011 Elsevier Inc. 795
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Figure 5. Translation of sprcRNAs
(A) Translational efficiency of putative lincRNAs. The translational efficiency, a normalized ratio of ribosome footprint density tomRNA-seq read density, is plotted
for the most highly occupied 90 nt window of each lincRNA, protein-coding gene, and coding transcript 30 UTR, along with a histogram of translational efficiency
values for CDSes and 30 UTRs and the median and quartile values for protein-coding genes.
(B) Ribosome footprint profile of the uc009lvh.1 transcript. This RNA is annotated as a noncoding RNA, but we identify two short (25 and 54 amino acids)
well-translated ORFs and see little translation from a longer (81 amino acid) downstream CDS hypothesized to encode a protein (Hassan et al., 2010).
(C) Ribosome footprint profile of the 2610001J05Rik genomic locus. The profile includes transcript-aligned reads mapped to corresponding genomic positions
and genomic-aligned reads with no transcript alignment. The annotated noncoding uc009ayt.1 transcript is shown along with the reconstructed transcript
(Guttman et al., 2010).
(D) Ribosome footprint profile of the uc009ayt.1 transcript.
See also Table S4.Widespread Translation of uORFs
The majority of unannotated near-cognate initiation sites we
detected drive the translation of upstream open reading frames
(uORFs) (Figures 6A and S4B). This is consistent with the high
level of translation that we observe onmany 50 UTRs as opposed
to 30 UTRs, which are almost devoid of ribosomes. These
uORF initiation sites are accompanied by elongating ribosome
footprints in the untreated sample that are depleted during
harringtonine treatment, indicating that they are involved in
active translation (Figure 4B). In a few well-studied examples,
uORFs have been shown to affect translation of downstream
genes. The first uORF in the Atf4 transcript is constitutively
translated, and ribosomes then reinitiate at either the second
uORF or the CDS (Calvo et al., 2009; Lu et al., 2004; Morris
and Geballe, 2000) (Figure 6B). This exemplifies two roles of
uORFs—some permit downstream reinitiation, whereas others
capture some fraction of scanning preinitiation complexes
and decrease CDS translation. There are a small number of
well-documented uORFs with near-cognate start codons
(Ivanov et al., 2008), but there are no effective computational
approaches for identifying them. Our observations suggest
that near-cognate uORFs are quite common. The ribosome
footprint profiles of Myc and Nanog, two genes that play a796 Cell 147, 789–802, November 11, 2011 ª2011 Elsevier Inc.critical role in pluripotency, illustrate the complexity of transla-
tion; both have multiple uORFs and alternate translation prod-
ucts initiating at both AUG and near-cognate sites (Figures 6C
and 6D).
Due to the prevalence of alternative transcription start sites
and alternative splicing, many genes have multiple 50 UTR
isoforms, potentially including distinct regulatory information
(Hughes, 2006). Many initiation sites occurred in alternative
UTRs; we found 1,800 genes showing differential initiation of
uORFs in distinct 50 UTR isoforms. We additionally observed
that at least 30% of these genes showed a significant difference
in the ratio of ribosome footprint to mRNA-seq reads between
the distinct 50 UTRs of different isoforms. Thus, alternative
splicing generates transcripts with different upstream initiation
sites and results in different uORF translation. For example, the
transcription factor Atf5 is regulated by well-characterized
uORFs in one mRNA isoform that are missing from a less-abun-
dant isoform expressed in early development (Hansen et al.,
2002). We observe robust translation initiation at a distinct
uORF in this second isoform (Figure 6E). Alternative inclusion
of uORFs was also seen in ribosomal proteins, including
Rps27a, where a small fraction of transcripts had a retained 50
UTR intron that introduced a uORF (Figure 6F). In the particular
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Figure 6. Translation of Regulatory uORFs and Alternatively Processed Transcripts
(A) Codon distribution at upstream (left) and internal (right) translation initiation sites. Internal sites are only taken from codons 15 through 300, as internal sites
further downstream are affected by incomplete ribosome run-off during short harringtonine treatment.
(B) Patterns of initiation and translation on the Atf4 transcript. The two characterized regulatory uORFs, initiated by AUG codons, are highlighted. Two weak
non-AUG reading frames are shown in blue.
(C) As in (B) on theMyc transcript. Several near-cognate sites of upstream initiation are shown, along with the annotated CUG initiation codon and the alternate
AUG initiation codon.
(D) As in (C) on the Nanog transcript. Upstream ORFs are shown, along with the CDS and two in-frame AUG initiation sites within the CDS.
(E) Patterns of initiation and translation on the 50 ends of two transcripts of the Atf5 gene. The exon structure is shown with thin gray rectangles for the 50 UTR
and thick gray rectangles for the annotated CDS. An mRNA-seq read profile is shown on an inverted y axis. Isoform-specific transcript positions are shown in
dark colors and non-isoform-specific positions are shown with faint colors. The major isoform (top) has two uORFs that confer translational regulation on the
CDS; a distinct uORF is observed in the minor embryonic isoform (bottom).
(F) As (E), for the 50 ends of the Rpl27a transcripts. Only the isoform-specific positions are shown for the minor isoform (bottom), scaled 103.
See also Figure S3.
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(A) Translational regulation following LIF withdrawal. The distribution of log2 fold-changes of translational efficiency (ratio of sample-normalized ribosome
footprint density to mRNA-seq density) is shown for all genes and for those with the GO annotation ‘‘structural constituent of ribosome’’ (see Table S5D). Inset:
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(B) Changes in relative upstream translation in EBs versus ESCs. The ratio of footprints between the 50 UTR and the ORF was computed for each gene, and the
distribution of log2 change in the 5
0 UTR/ORF ratio is plotted, with decreases in EB shown in blue and increases in EB shown in yellow.
(C and D) Patterns of translation on the Ccnb5 (C) and Anapc5 (D) transcripts. Ribosome footprints that map to the 50 UTR are in dark colors, and the CDS in faint
colors. The average, sample-normalized ribosome footprint density on the CDS is slightly higher in the EB sample than in the ESC sample for both.
See also Figure S4 and Table S5.case of isoforms where an alternative UTR splice junction is
quite close to the shared start codon, ribosome footprints from
initiation at the start codon can include enough distinct upstream
sequence to distinguish the effect of different UTRs. The gene
Pih1d1 has two 50 UTR variants with distinct uORFs. Strong
initiation of the uORF in one isoform led to 50% less initiation
of its protein-coding reading frame as compared to initiation of
the same protein-coding reading frame in the second isoform
(Figure S3). This effect demonstrates the potential impact of
the widespread upstream initiation we observe in both alterna-
tive and constitutive 50 UTRs.
Changes in Translation during Embryoid Body
Formation
We next asked how the landscape of translation changes when
proliferative, pluripotent ESCs undergo differentiation into
embryoid bodies (EBs). Withdrawal of leukemia inhibitory factor
(LIF) induced differentiation (Figure S4A), which we assessed
visually and by the downregulation of the direct LIF target Klf4
(Niwa et al., 2009), followed by loss of Oct4 expression and the
induction of developmental and lineage-specific genes (Figures
S4B and S4C and Tables S5A–S5F). We then looked for transla-
tional control of gene expression during differentiation and
observed strong repression of ribosomal proteins (RPs) in EBs
relative to ESCs (Figures 7A and S4D and Table S5F). Although
these genes were still highly expressed in EBs, they were798 Cell 147, 789–802, November 11, 2011 ª2011 Elsevier Inc.translated 3- to 4-fold less efficiently than the typical transcript
(Tables S5D–S5F). The translation of RPs is regulated in
response to proliferation and nutrient status (Hamilton et al.,
2006), and here we show that this response is a notable feature
of EB formation. Polysome-profiling experiments have sug-
gested a global increase in cellular translation during early ESC
differentiation, and we see a modest upregulation of RPs in our
early time point (Sampath et al., 2008). Thismight lead to a surfeit
of ribosomes at the later stage of EB formation. Intriguingly,
Akt/mTOR signaling controls RP expression and may regulate
translation during differentiation more generally (Di Cristofano
et al., 1998; Sampath et al., 2008). We also observed a modest
but quite significant increase in the translational efficiency of
integral membrane proteins in EBs (Figure S4E and Table S5F),
which could result directly from a redirection of ribosomes to
the rough ER, or indirectly through regulatory programs whose
targets are enriched for membrane proteins.
Translation of uORFs also declined substantially during differ-
entiation. We measured the level of upstream translation using
the ratio of ribosome footprint reads in the 50 UTR to the CDS
of each gene and found that the typical transcript showed an
25% decrease in 50 UTR translation during differentiation
(Figure 7B). This shift can be observed on the 50 UTR of individual
genes with defined uORFs (Figures 7C and 7D). It reflects
a broad change in the translational apparatus with the potential
to impact gene expression genome-wide. Reduced upstream
translation might reflect a relative decrease in cap-dependent
versus cap-independent initiation, as cap-dependent initiation
would be expected to favor upstream sites near the cap. Such
a shift has been associated with proliferation in tumorigenesis
and has been linked to the translational control of RPs (Mamane
et al., 2006; Ruggero and Sonenberg, 2005). This tumor cell
translational program may also be active in ESCs.
DISCUSSION
Here we present a range of ribosome-profiling techniques,
based on deep sequencing of ribosome-protected fragments,
that dramatically expand our ability to define and quantitatively
monitor mammalian proteomes. Our approaches provide
experimentally based maps of the protein-coding potential of
complex genomes and reveal in-depth information about the
kinetics and mechanism of translation elongation and coupled
cotranslational events. Finally, ribosome profiling allows
high-precision, genome-wide measures of the rate of protein
synthesis from the density of ribosome footprints, much as
RNA-seq experiments measure mRNA abundance from read
density; such gene expression measurements may represent
the most frequent application of ribosome profiling even after
the proteome is fully defined. Although there have been remark-
able advances in quantitative mass spectrometry (Nilsson et al.,
2010), it is difficult to match the large dynamic range and
comprehensive nature of deep sequencing. More generally
mass spectrometry and ribosome profiling represent highly
complementary approaches; for example, comparison between
changes in rate of synthesis measured by ribosome profiling
and abundance measured by mass spectrometry should
reveal examples of regulated degradation of proteins.
A number of features of mammalian proteomes emerge from
our studies, including the ubiquitous use of alternate initiation
sites that drive the production of extended or truncated iso-
forms of known proteins as well as the translation of sprcRNAs,
whose protein-coding potential was not initially apparent. We
also observe widespread translation upstream of mammalian
protein-coding genes, similar to but more extensive than
upstream translation that we observed in yeast (Ingolia et al.,
2009). Translation of uORFs can modulate the expression of
the downstream protein-coding gene in response to global
(Sonenberg and Hinnebusch, 2009) or gene-specific regulatory
signals (Medenbach et al., 2011). We have shown that upstream
translation decreases as ESCs undergo differentiation, indi-
cating that it is subject to regulation and may be part of a major
program of translational control.
Our studies also establish that many sites of translation initi-
ation, especially upstream initiation, occur at non-AUG codons.
Although most productive protein synthesis starts at a classical
AUG codon, initiation at CUG and GUG codons is widespread
and is likely to have broad biological significance. An important
open question is how this non-AUG initiation differs mechanis-
tically from AUG initiation and what factors regulate initiation
site selection. The bias toward upstream non-AUG initiation
seems to conflict with a pure scanning model for start codon
recognition, as a preinitiation complex that bypasses the
annotated AUG is no less likely to recognize a subsequentCUG, though the difference could reflect heterogeneous strin-
gencies in scanning complexes.
Non-AUG initiation clearly impacts many aspects of transla-
tion. The extensive upstream non-AUG initiation we observe is
likely to regulate protein synthesis from specific transcripts in
response to global changes in initiation. It is also regulated
during EB formation, suggesting a global link with growth and
proliferation, and is involved in the synthesis of functional
proteins, including the well-studied oncogene and pluripotency
factor Myc (Hann et al., 1988). More broadly, it has been
implicated in the production of peptides for immune surveillance
(Malarkannan et al., 1999), and additional roles will likely emerge
as we understand more about which non-AUG codons are used
and how this selection is regulated.
EXPERIMENTAL PROCEDURES
Ribosome Footprinting
E14 mESCs were propagated in standard culture feeder-free conditions
(Tremml et al., 2008), and differentiation was induced by transferring cells
to media lacking LIF in low-adhesion dishes. Cells were pretreated with har-
ringtonine (2 mg/ml), cycloheximide (100 mg/ml), and/or emetine (20 mg/ml)
as indicated, and detergent lysis was performed in the dish. The lysate was
DNase-treated and clarified, and a sample was taken for mRNA-Seq analysis.
Lysates were subject to ribosome footprinting by nuclease treatment. Foot-
print fragments were purified, and deep sequencing libraries were generated
from these fragments, as well as from poly(A) mRNA purified from untreated
lysate. These libraries were analyzed by sequencing on the Illumina GAII
and HiSeq.
Footprint Sequence Alignment
Sequences were aligned to a library of transcripts derived from the UCSC
Known Genes data set (Hsu et al., 2006) and the reconstructed mESC tran-
scriptome of Guttman et al. (Guttman et al., 2010), and those with no accept-
able transcript alignment were then aligned against the genome. Because
sequencing reads comprise a variable-length RNA fragment followed by a
linker sequence, the first 26 nucleotides were aligned against the reference
database using Bowtie, and this alignment was extended until it reached
the known linker sequence. Alignments were accepted with up to two
mismatches, and multiple alignments were allowed for a single sequence,
but alignments with fewer mismatches were preferred.
For most analyses, footprint alignments were assigned to specific A site
nucleotides by using the position and total length of each alignment, calibrated
from footprints at the beginning and the end of CDSes (Figures S1A and S1B)
as previously described (Ingolia et al., 2009).
Footprint Profile Analysis
Profiles of ribosome footprints across a transcript were constructed by
quantifying the number of footprints assigned to each nucleotide position.
A set of well-expressed genes was selected based on median footprint
density across the CDS, excluding the first 15 and last 5 codons due to the
accumulation of ribosomes (Figures 1C and 1D). To construct metagene
density profiles, individual gene profiles were scaled by their footprint density
in the untreated control, and all were averaged with equal weight.
Harringtonine Depletion Profile Analysis
Metagene profiles from harringtonine run-off were further normalized by the
median value over codons 800–1000, which appeared undepleted at harring-
tonine treatment times used in this study, and smoothed by averaging disjoint
5 codon windows. The extent of depletion was defined as the earliest codon
position, beyond the first 40, that retained at least 50% of the full ribosome
density. Subsets of genes for elongation rate analysis were as follows: (1)
lowest and highest quintile of tAI, computed according to dos Reis et al.
(2004); (2) lowest and highest quintile of ribosome footprint density; (3) shortCell 147, 789–802, November 11, 2011 ª2011 Elsevier Inc. 799
genes, 750–1,000 codons, and long genes, over 1,000 codons; (4) secreted
proteins that were identified using SignalP data from Ensembl.
Initiation Site Prediction
Initiation site predictions for each nucleotide position were based on a vector
of footprint read counts over 15 codons around the position for each harring-
tonine sample, concatenated to produce an overall vector. The SVMlight
pattern-recognition tool (Joachims, 1999) was trained on an arbitrary set of
3,200 transcripts, using the annotated start codon as a positive example
and ten other positions as negative examples.
Initiation sites were defined as one or more consecutive nucleotide positions
that passed an SVM score threshold as well as a minimum of 50 harringtonine
footprints total among all samples. These consecutive blocks were typically
(91%) three or fewer nucleotides long and in no case longer than six nucleo-
tides (Table S3). Initiation sites that contained an AUG codon were assigned
to that codon or, if none was present, to any near-cognate codons, and the
reading frame was predicted from that codon. Sites with no recognizable
initiation codon or with multiple potential near-cognate codons could not
be assigned to a specific reading frame and were eliminated from further
analyses. The preferential assignment of initiation sites to AUG codons may
lead to a modest bias against detecting near-cognate initiation.
lincRNA Analysis
lincRNAs were collected from reconstructed transcripts (Guttman et al., 2010)
that lay entirely within the lincRNA chromatin signatures identified by Guttman
et al. (2009), which excluded known protein-coding genes. Footprint density
profiles from the untreated sample were analyzed to identify the 90 nt window
with the most positions occupied by at least one ribosome footprint among
all transcripts in the chromatin region. For annotated protein-coding tran-
scripts, the CDS and the 30 UTR were analyzed separately. The mRNA
abundance was calculated as the density of mRNA-seq reads in the window,
and the translational efficiency was calculated as the ratio between the ribo-
some footprint and the mRNA-seq read density in the window.
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